We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Microplastics: Clinical Trials Perspectives
Summary
This mini review covers the current state of clinical research on microplastics in the human body. Tiny plastic particles have been found in human blood and organs, but studying their effects is challenging due to a lack of standardized methods and ethical guidelines for human trials. The paper highlights that while lab and animal studies provide early data, much more work is needed to understand what microplastics do inside us.
Plastic pollution has emerged as one of the global challenges for the humanity. Plastics particles of millimeter and micrometer dimensions have been detected everywhere in the environment. Detection of tiny plastic particles in human blood and different organs has caused serious concerns and awareness in the society. Research activities have been initiated globally f or better understanding the possible routes of entry and translocation of micro-and nano-plastics in human body. In vitro and in vivo studies have generated some primary data on these aspects. However, the major challenges in gathering data from clinical studies are lack of established methodology for designing ethically correct experiments, detection and identification of plastic particles and regulatory guidelines that needs to be designed specifically for micro-and nanoplastics. In this mini review article, readers are navigated through the recent updates on the clinical studies with microplastics and current challenges with some critical inputs.
Sign in to start a discussion.
More Papers Like This
Microplastics: challenges of assessment in biological samples and their implication for in vitro and in vivo effects
This review examines the challenges of detecting and assessing microplastics in biological samples, noting that analytical limitations and lack of standardized methods hinder our understanding of health effects. The study highlights that humans are exposed to microplastics primarily through ingestion and inhalation, and that more long-term studies with standardized protocols are needed to understand the full scope of potential biological impacts.
Microplastics: challenges of assessment in biological samples and their implication for in vitro and in vivo effects
This review covers how microplastics enter the human body through ingestion and inhalation, the challenges of detecting and measuring them in biological samples, and the evidence for harmful effects ranging from inflammation to hormonal disruption. Standardising methods for measuring microplastics in tissues and bodily fluids is a key obstacle to advancing human health research. The review provides a useful framework for understanding what we know and what still needs to be established about microplastic risks to people.
[Clinical impact of microplastic exposure in humans].
This German-language clinical review summarized current knowledge on microplastic exposure pathways, health risks, and the World Health Organization's assessment of this topic. The authors noted significant gaps in measuring microplastics in the human body and called for improved methods to assess clinical impacts, particularly links to infectious disease.
Microplastics and Human Health: A Comprehensive Review on Exposure Pathways, Toxicity, and Emerging Risks
This comprehensive review examines microplastic exposure pathways in humans, methods of detection, and the potential toxic effects on various biological systems. The study highlights growing evidence that microplastics can enter the body through ingestion, inhalation, and dermal contact, and may affect multiple organ systems, though significant uncertainties remain about long-term health outcomes.
Understanding Human Health Impacts Following Microplastic Exposure Necessitates Standardized Protocols
This overview examines the methods currently used to study how microplastics affect human health, highlighting significant inconsistencies in experimental approaches. Researchers identified challenges including the lack of standardized reference materials, variability in exposure conditions, and limited understanding of how microplastic doses translate to real-world exposure. The study proposes solutions to standardize protocols so that future research builds on a more reliable foundation.